Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 188

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 188
---
 provided by each director concerning his background, employment and affiliations, each of the directors on the TuHURA Board of Directors, other than Dr. James Bianco and Robert E. Hoffman, qualify as independent directors, as defined under Nasdaq listing rules (the “Nasdaq listing rules”), and the TuHURA Board of Directors consists of a majority of “independent directors,” as defined under the rules of the SEC and Nasdaq listing rules relating to director independence requirements. In addition, TuHURA is subject to the rules of the SEC and Nasdaq relating to the membership, qualifications, and operations of certain committees of the TuHURA Board of Directors, as discussed below

TuHURA Board of Directors Committees

The TuHURA Board of Directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee, each of which operate pursuant to a charter adopted by the TuHURA Board of Directors. The TuHURA Board of Directors may also establish other committees from time to time to assist TuHURA and the TuHURA Board of Directors.

Audit Committee

The audit committee oversees and monitors TuHURA’s financial reporting process and internal control system, reviews and evaluates the audit performed by TuHURA’s registered independent public accountants and reports to the TuHURA Board of Directors any substantive issues found during the audit. The audit committee is directly responsible for the appointment, compensation and oversight of the work of TuHURA’s registered independent public accountants. The audit committee reviews and approves all transactions with affiliated parties.

The audit committee consists of James Manuso, Ph.D., MBA (chairman), Alan List, M.D., and George Ng. The TuHURA Board of Directors has also reviewed the education, experience and other qualifications of each member of the audit committee and based upon such review, has determined that Dr. Manuso is an “audit committee financial expert”, as defined by the rules of the SEC.

To qualify as independent to serve on TuHURA’s audit committee, listing standards of Nasdaq and the applicable SEC rules require that a director not accept any consulting, advisory or other compensatory fee from TuHURA, other than for service as a director, or be an affiliated person of TuHURA.

Compensation Committee

The compensation committee assists the TuHURA Board of Directors in fulfilling its oversight responsibilities relating to (i) corporate governance practices and policies and (ii) compensation matters, including compensation of the directors and senior management of TuHURA and the administration of compensation